LABORATORIO FARMAC.ERFO Cash Flow Quality Index
LABORATORIO FARMAC.ERFO cash flow quality index. LABORATORIO FARMAC.ERFO (RK7) has a Cash Flow Quality Index of 2.20x as of December 2023. Operating cash flow of €1.30 Million exceeds net income of €590.33K, indicating high earnings quality where cash backs reported profits. See LABORATORIO FARMAC.ERFO (RK7) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of LABORATORIO FARMAC.ERFO (2021–2023)
Cash flow quality index of LABORATORIO FARMAC.ERFO from 2021 to 2023. Historical Cash Flow Quality Index for LABORATORIO FARMAC.ERFO across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of LABORATORIO FARMAC.ERFO to assess how comfortably operating cash covers total debt obligations.
LABORATORIO FARMAC.ERFO Cash Flow Quality Index by Year (2021–2023)
LABORATORIO FARMAC.ERFO cash flow quality index by year from 2021 to 2023. Year-by-year earnings quality comparison for LABORATORIO FARMAC.ERFO. For the full cash flow conversion analysis, see RK7 operating cash flow.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 2.20x | €1.30 Million | €590.33K | ▲ +106.5% |
| 2022 | 1.06x | €761.80K | €716.07K | ▼ -45.8% |
| 2021 | 1.96x | €2.27 Million | €1.16 Million | — |